在大肠杆菌中以异构集成辅助的代谢工程为目的,提高D-潘托酸的产量
Kuo Zhao1, Hailin Gao1, Mengnan Han1
1Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310014, China; Engineering Research Center of Bioconversion and Biopurification of Ministry of Education, Zhejiang University of Technology, Hangzhou, 310014, China; State Key Laboratory of Green Chemical Synthesis and Conversion, Zhejiang University of Technology, Hangzhou, 310014, PR China.
Metabolic engineering
|August 13, 2025
概括
通过优化代谢途径和运输系统来提高D-pantothenic acid (D-PA) 生产的工程大肠杆菌. 这导致高D-PA标位为98.6g/L,促进了工业微生物生产.
科学领域:
- 生物技术是生物技术.
- 代谢工程是代谢工程.
- 微生物生产 微生物生产
背景情况:
- D-潘托酸 (D-PA) 是一种必需的维生素,有着重要的工业需求.
- 高效的D-PA微生物生产对于满足工业需求至关重要.
- 大肠杆菌是代谢工程的合适宿主,因为它具有良好的特征路径.
研究的目的:
- 为了改造一种大肠杆菌菌株以提高D-pantothenic acid (D-PA) 的产量.
- 为了改善碳利用,辅因子的可用性和D-PA生物合成途径.
- 通过综合代谢工程策略实现高位数D-PA的产生.
主要方法:
- 消除竞争的副产品通路,并降低酸通路的调节.
- 增强葡萄糖和β-氨酸运输系统,并优化NADPH/ATP再生.
- 介绍一个异质的5,10-甲基基酸生物合成模块和关键酶的动态调节.
主要成果:
- 工程品种DPZ28/P31的D-PA标位达到98.6g/L.
- 在料批发发酵中获得0.44g/g葡萄糖的高D-PA产量.
- 综合代谢工程策略显著增强了D-PA生物合成.
结论:
- 对大肠杆菌的合理代谢工程可以实现高水平的D-潘托酸生产.
- 优化碳流量,辅因子再生和特定路径工程是有效的D-PA生物合成的关键.
- 开发的菌株和发酵策略为工业D-PA制造提供了一个有前途的平台.
相关概念视频
Evolution of New Traits in Microbes
199
Microorganisms evolve rapidly due to their large population sizes and short generation times, often exhibiting measurable changes within days under laboratory conditions. Natural selection acts on standing genetic variation, enabling the retention and amplification of beneficial traits that confer fitness advantages in changing environments.Adaptive Pigment Regulation in RhodobacterIn Rhodobacter, a genus of purple non-sulfur bacteria, light-harvesting pigments such as bacteriochlorophyll and...
199
Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Production of Pharmaceuticals
94
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94


